TIAA CREF Investment Management’s Neurocrine Biosciences NBIX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
$46.2M Buy
524,465
+293,210
+127% +$25.8M 0.03% 427
2018
Q4
$16.5M Sell
231,255
-95,643
-29% -$6.83M 0.01% 717
2018
Q3
$40.2M Buy
326,898
+4,655
+1% +$572K 0.03% 506
2018
Q2
$31.7M Buy
322,243
+14,425
+5% +$1.42M 0.02% 578
2018
Q1
$25.5M Sell
307,818
-44,298
-13% -$3.67M 0.02% 653
2017
Q4
$27.3M Buy
352,116
+44,642
+15% +$3.46M 0.02% 641
2017
Q3
$18.8M Sell
307,474
-21,561
-7% -$1.32M 0.01% 787
2017
Q2
$15.1M Buy
329,035
+57,371
+21% +$2.64M 0.01% 895
2017
Q1
$11.8M Buy
271,664
+39,717
+17% +$1.72M 0.01% 1014
2016
Q4
$8.98M Buy
231,947
+49,982
+27% +$1.93M 0.01% 1194
2016
Q3
$9.22K Buy
181,965
+8,775
+5% +$444 0.01% 1178
2016
Q2
$7.87M Sell
173,190
-178,008
-51% -$8.09M 0.01% 1218
2016
Q1
$13.9M Buy
351,198
+24,842
+8% +$983K 0.01% 885
2015
Q4
$18.5M Buy
326,356
+21,179
+7% +$1.2M 0.01% 785
2015
Q3
$12.1M Buy
305,177
+13,698
+5% +$545K 0.01% 946
2015
Q2
$13.9M Buy
291,479
+5,579
+2% +$266K 0.01% 939
2015
Q1
$11.4M Buy
285,900
+17,523
+7% +$696K 0.01% 1060
2014
Q4
$6M Sell
268,377
-33,034
-11% -$738K ﹤0.01% 1499
2014
Q3
$4.72M Sell
301,411
-7,351
-2% -$115K ﹤0.01% 1659
2014
Q2
$4.58M Buy
308,762
+14,726
+5% +$219K ﹤0.01% 1750
2014
Q1
$4.73M Buy
294,036
+7,511
+3% +$121K ﹤0.01% 1653
2013
Q4
$2.68M Hold
286,525
﹤0.01% 2074
2013
Q3
$3.24M Sell
286,525
-7,318
-2% -$82.8K ﹤0.01% 1900
2013
Q2
$3.93M Buy
+293,843
New +$3.93M ﹤0.01% 1695